Managers / Q3 2021 · view latest →
Capital Impact Advisors, LLC
CIK 0001602198 · 175 FEDERAL ST, SUITE 875, BOSTON, MA, 02110 · 617-279-0045
Summary
Capital Impact Advisors, LLC reported $252M in U.S.-listed holdings across 122 positions for Q3 2021.
Its largest position, GOOGL, represents 2.8% of the portfolio.
Compared with Q2 2021, the fund opened 11 new positions and exited 16.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.6% · $241M
- Other · 1.6% · $4M
- REIT · 1.4% · $4M
- ADR · 1.4% · $3M
Quarter-over-Quarter Changes full breakdown →
vs Q2 2021 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| ANAUTONATION INC | NEW | +24.6K | 24.6K | +$3M | $3M |
| PLTRPALANTIR TECHNOLOGIES INC | NEW | +101.0K | 101.0K | +$2M | $2M |
| EXLSEXLSERVICE HOLDINGS INC | NEW | +18.9K | 18.9K | +$2M | $2M |
| RMERESMED INC | NEW | +5.4K | 5.4K | +$1M | $1M |
| AMEDAMEDISYS INC | NEW | +9.4K | 9.4K | +$1M | $1M |
| SEDGSOLAREDGE TECHNOLOGIES INC | NEW | +4.7K | 4.7K | +$1M | $1M |
| NTLAINTELLIA THERAPEUTICS INC | NEW | +7.5K | 7.5K | +$1M | $1M |
| FRCBFIRST REP BK SAN FRANCISCO C | NEW | +3.3K | 3.3K | +$643,000 | $643,000 |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q3 2021
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $247M | 30 | May 15, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.3B | 30 | Feb 17, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $447M | 30 | Nov 14, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $332M | 30 | Aug 18, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | Under review | 30 | May 20, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $3M | 1 | Nov 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $36M | 53 | Aug 16, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $77M | 92 | May 15, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $76M | 92 | Feb 14, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $60M | 109 | Nov 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $91M | 174 | Aug 14, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $82M | 177 | May 23, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $102M | 236 | Feb 15, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $100M | 237 | Nov 22, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $108M | 226 | Aug 15, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $138M | 187 | May 16, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $145M | 97 | Feb 14, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $252M | 122 | Nov 15, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $310M | 127 | Aug 17, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $286M | 109 | May 18, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $407M | 102 | Feb 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $337M | 109 | Nov 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $299M | 114 | Aug 17, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $238M | 107 | May 15, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $284M | 115 | Feb 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $262M | 130 | Nov 14, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $273M | 131 | Jul 19, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $226M | 128 | Apr 17, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.